Cost-benefit analysis of exchange transfusion for acute bilirubin encephalopathy
10.3969/j.issn.1671-8348.2013.31.003
- VernacularTitle:换血疗法治疗急性胆红素脑病的成本效益分析
- Author:
Huifan LI
;
Huayun HE
;
Kaizhen LIU
- Publication Type:Journal Article
- Keywords:
infant,newborn;
acute bilirubin encephalopathy;
exchange transfusion;
cost-benefit analysis
- From:
Chongqing Medicine
2013;(31):3728-3731
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the cost-benefit of exchange transfusion(ET ) in the treatment of different severity of acute bili-rubin encephalopathy(ABE) .Methods Retrospective analysis was carried out on the clinical data of 137 ABE from January 2009 to December 2010 .The enrolled neonates were divided into four groups by ABE severity and interventions :40 neonates in Group SE (Subtle ABE with ET ) ,29 in Group SNE (Subtle ABE without ET ) ,49 in Group ME (Moderate to advanced ABE with ET ) ,and 19 in Group MNE (Moderate to advanced ABE without ET ) .Results The Total Serum Bilirubin (TSB) levels ,the ratio of TSB and plasma albumin (B/A) ,the proportion of neonatal hemolysis disease and the hospitalization costs per capita in Group SE were significantly higher than those in Group SNE (P<0 .05) .Without death in subtle ABE ,the rate of poor outcomes in Group SE , 15 .0% was similar to that of Group SNE ,13 .8% .The maximum benefit-cost ratio of Group SE and Group SNE was 87 .5 and 121 .5 ,respectively .The TSB levels ,B/A ,the proportion of neonatal hemolysis disease and the hospitalization costs per capita in Group ME significantly higher those in Group MNE (P<0 .05) .5 neonates died in moderate to advanced ABE ,and the incidence of poor outcomes in Group ME ,32 .7% was 2 .1 times to that of Group MNE ,15 .8% .The maximum benefit-cost ratio of Group ME and Group MNE was 89 .8 and 160 .0 ,respectively .The TSB levels and B/A in Group ME significantly higher those in Group SE (P<0 .05) ,the incidence of poor outcomes in Group ME was 2 .2 times to that of Group SE ,whereas the hospitalization costs per capita in Group ME were similar to those in Group SE (P>0 .05) .Morbidity of the severe adverse events associated with ET in Group ME ,12 .2% was 2 .4 times to that of Group SE ,5 .0% .Conclusion ET is worth of the first-line approach rescuing subtle ABE .However ,ET is needed to be weighted the advantages and disadvantages before performed on moderate or advanced ABE .It is necessary to implement phototherapy among neonates with pathologic jaundice ,which is crucial for diminishing mortality and mor-bidity of ABE and lowering medical resource consumption .
